Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers.

abstract：:The carcinogenicities of a choline deficient L-amino acid defined (CDAA) diet and a semipurified choline deficient diet were comparatively examined. A total of 60 male Fischer 344 rats, 6 weeks old, were divided into 5 experimental groups each consisting of 12 rats. Group 1 received the CDAA diet chronically to the en...

journal_title：Cancer research

authors： Nakae D,Yoshiji H,Mizumoto Y,Horiguchi K,Shiraiwa K,Tamura K,Denda A,Konishi Y

更新日期：1992-09-15 00:00:00

abstract：:Caveolin-1 (CAV1) is the main structural component of caveolae, which are plasma membrane invaginations that participate in vesicular trafficking and signal transduction events. Although evidence describing the function of CAV1 in several cancer types has recently accumulated, its role in melanoma tumor formation and ...

journal_title：Cancer research

authors： Trimmer C,Whitaker-Menezes D,Bonuccelli G,Milliman JN,Daumer KM,Aplin AE,Pestell RG,Sotgia F,Lisanti MP,Capozza F

更新日期：2010-10-01 00:00:00

abstract：:Smad3, a major intracellular mediator of TGFβ signaling, functions as both a positive and negative regulator in carcinogenesis. In response to TGFβ, the TGFβ receptor phosphorylates serine residues at the Smad3 C-tail. Cancer cells often contain high levels of the MAPK and CDK activities, which can lead to the Smad3 l...

journal_title：Cancer research

authors： Bae E,Sato M,Kim RJ,Kwak MK,Naka K,Gim J,Kadota M,Tang B,Flanders KC,Kim TA,Leem SH,Park T,Liu F,Wakefield LM,Kim SJ,Ooshima A

更新日期：2014-11-01 00:00:00

abstract：:A phase I clinical trial with granulocyte-macrophage colony-stimulating factor tumor cell vaccines in patients with metastatic renal cell carcinoma (RCC) showed immune cell infiltration at vaccine sites and delayed-type hypersensitivity (DTH) responses to autologous tumor cells indicative of T-cell immunity. To furthe...

journal_title：Cancer research

authors： Zhou X,Jun DY,Thomas AM,Huang X,Huang LQ,Mautner J,Mo W,Robbins PF,Pardoll DM,Jaffee EM

更新日期：2005-02-01 00:00:00

abstract：:All mammalian cells express 3 closely related Ras proteins, termed H-Ras, K-Ras, and N-Ras, that promote oncogenesis when they are mutationally activated at codon 12, 13, or 61. Although there is a high degree of similarity among the isoforms, K-Ras mutations are far more frequently observed in cancer, and each isofor...

journal_title：Cancer research

authors： Prior IA,Lewis PD,Mattos C

更新日期：2012-05-15 00:00:00

abstract：:Induction of T-cell activation requires multiple signals provided by cell surface receptor interactions and/or cytokines. T-cell stimulation via the T-cell receptor/CD3 complex provides an important initial activation event which, when combined with the proper costimulatory signals, results in an activated effector T ...

journal_title：Cancer research

authors： Kroesen BJ,Bakker A,van Lier RA,The HT,de Leij L

更新日期：1995-10-01 00:00:00

abstract：:This paper describes the use of the bromodeoxyuridine/propidium iodide method to assess the effects of bioactive and cytotoxic agents on the kinetic characteristics of acute myelogenous leukemia cells. By careful selection of gates, the following parameters can be measured simultaneously using only 50,000 cells: the p...

journal_title：Cancer research

authors： Preisler HD,Gopal V,Banavali SD,Finke D,Bokari SA

更新日期：1992-08-01 00:00:00

abstract：:Angiogenesis is required for tumor formation. Several studies have demonstrated that tumor angiogenesis is regulated by a balance between proangiogenesis and antiangiogenesis factors and that this balance varies in different organ environments. To investigate whether expression of an angiogenesis inhibitor by cancer c...

journal_title：Cancer research

authors： Yoon SS,Eto H,Lin CM,Nakamura H,Pawlik TM,Song SU,Tanabe KK

更新日期：1999-12-15 00:00:00

abstract：:The biodistribution characteristics of a humanized anti-Lewis(y) antibody (hu3S193) radiolabeled to three radioisotopes, 125I, 111In, and 90Y, were examined in a BALB/c nude mouse xenograft model of breast cancer. The immunoreactivity of both 125I- and 111In-bound hu3S193 exceeded 50% and was 20% for 90Y. In vivo, lab...

journal_title：Cancer research

authors： Clarke K,Lee FT,Brechbiel MW,Smyth FE,Old LJ,Scott AM

更新日期：2000-09-01 00:00:00

abstract：:DDX3 is a DEAD box RNA helicase with diverse biological functions. Using colony formation assay, our results revealed that DDX3 inhibited the colony formation ability of various tumor cells, and this inhibition might be due to a reduced growth rate caused by DDX3. Additionally, we identified p21(waf1/cip1), a cyclin-d...

journal_title：Cancer research

authors： Chao CH,Chen CM,Cheng PL,Shih JW,Tsou AP,Lee YH

更新日期：2006-07-01 00:00:00

abstract：:Overexpression of colony-stimulating factor-1 (CSF-1) and its receptor in breast cancer is correlated with poor prognosis. Based on the hypothesis that blockade of CSF-1 would be beneficial in breast cancer treatment, we developed a murinized, polyethylene glycol-linked antigen-binding fragment (Fab) against mouse (ho...

journal_title：Cancer research

authors： Paulus P,Stanley ER,Schäfer R,Abraham D,Aharinejad S

更新日期：2006-04-15 00:00:00

abstract：:In acute promyelocytic leukemia (APL), all-trans retinoic acid (ATRA) treatment induces granulocytic maturation and complete remission of leukemia. microRNAs are known to be critical players in the formation of the leukemic phenotype. In this study, we report downregulation of the miR-181a/b gene cluster in APL blasts...

journal_title：Cancer research

authors： Bräuer-Hartmann D,Hartmann JU,Wurm AA,Gerloff D,Katzerke C,Verga Falzacappa MV,Pelicci PG,Müller-Tidow C,Tenen DG,Niederwieser D,Behre G

更新日期：2015-08-15 00:00:00

abstract：:Papillomas induced in SENCAR mice by initiation with 7,12-dimethylbenz(a)anthracene and promotion by treatment for 10-12 weeks with 12-O-tetradecanoylphorbol-13-acetate (TPA) convert to malignancy at a low frequency. The rate of malignant conversion can be increased by either (a) promoting with TPA for a shorter durat...

journal_title：Cancer research

authors： Hennings H,Shores R,Balaschak M,Yuspa SH

更新日期：1990-02-01 00:00:00

abstract：:A case-control study of 229 ovarian cancer cases (including 172 epithelial tumors) and an equal number of population-based controls was conducted during 1984 to 1986 in Shanghai, China, a low-risk area for ovarian cancer. Similar to studies in high-risk areas, the risk of epithelial tumors was high for nulliparous wom...

journal_title：Cancer research

authors： Shu XO,Brinton LA,Gao YT,Yuan JM

更新日期：1989-07-01 00:00:00

abstract：:DNA methylation was measured in human tumor cell lines and freshly explanted pediatric tumors by [3H]uridine labeling followed by DNA hydrolysis and high-performance liquid chromatography. The percentage of cytosine residues modified to 5-methylcytosine in 4 cell lines derived from pediatric tumors was increased or si...

journal_title：Cancer research

authors： Flatau E,Bogenmann E,Jones PA

更新日期：1983-10-01 00:00:00

abstract：:Borderline ovarian tumors possess many of the same morphological features as their malignant counterparts, but they do not destructively invade the ovarian stroma, and the women in whom they develop generally have a favorable prognosis. Female residents of three urban counties of western Washington diagnosed with sero...

journal_title：Cancer research

authors： Harlow BL,Weiss NS,Roth GJ,Chu J,Daling JR

更新日期：1988-10-15 00:00:00

abstract：:Modern cancer therapy/care involves the integration of basic, clinical, and population-based research professionals using state-of-the-art science to achieve the best possible patient outcomes. A well-integrated team of basic, clinical, and population science professionals and educators working with a fully engaged gr...

journal_title：Cancer research

authors： Welch DR,Antalis TM,Burnstein K,Vona-Davis L,Jensen RA,Nakshatri H,Riegel AT,Spitz DR,Watson DK,Weiner GJ,Cancer Biology Training Consortium.

更新日期：2015-12-15 00:00:00

abstract：:Patients with lung cancer often present with metastatic disease and therefore have a very poor prognosis. The recent discovery of several novel ROS receptor tyrosine kinase molecular alterations in non-small cell lung cancer (NSCLC) presents a therapeutic opportunity for the development of new targeted treatment strat...

journal_title：Cancer research

authors： Jun HJ,Johnson H,Bronson RT,de Feraudy S,White F,Charest A

更新日期：2012-08-01 00:00:00

abstract：:G protein-coupled receptors (GPCR) and the epidermal growth factor receptor (EGFR) are often both overexpressed and contribute to the growth of cancers by activating autocrine pathways. GPCR ligands have been reported to trigger EGFR signaling via receptor cross-talk in cancer cells. Here, we show that GPCR ligands pr...

journal_title：Cancer research

authors： Thomas SM,Bhola NE,Zhang Q,Contrucci SC,Wentzel AL,Freilino ML,Gooding WE,Siegfried JM,Chan DC,Grandis JR

更新日期：2006-12-15 00:00:00

abstract：:Slow-clearing, tumor-targeting proteins such as monoclonal antibodies typically exhibit high tumor accumulation but low tissue contrast, whereas intermediate-sized proteins such as scFvs show faster clearance but only moderate tumor accumulation. For both, tumor targeting does not seem to improve further above an opti...

journal_title：Cancer research

authors： Zahnd C,Kawe M,Stumpp MT,de Pasquale C,Tamaskovic R,Nagy-Davidescu G,Dreier B,Schibli R,Binz HK,Waibel R,Plückthun A

更新日期：2010-02-15 00:00:00

abstract：:CXCL16 is a new member of the chemokine superfamily, which exists in a transmembrane as well as a soluble form. Its receptor CXCR6 is detected on CD4(+) T cells, CD8(+) T cells, and natural killer T cells. Here, we report a significant correlation of CXCL16 expression by tumor cells with the infiltration of T cells an...

journal_title：Cancer research

authors： Hojo S,Koizumi K,Tsuneyama K,Arita Y,Cui Z,Shinohara K,Minami T,Hashimoto I,Nakayama T,Sakurai H,Takano Y,Yoshie O,Tsukada K,Saiki I

更新日期：2007-05-15 00:00:00

abstract：:The Bcl-2 antagonist ABT-737 targets Bcl-2/Bcl-xL but not Mcl-1, which may confer resistance to this novel agent. Here, we show that Mcl-1 down-regulation by the cyclin-dependent kinase (CDK) inhibitor roscovitine or Mcl-1-shRNA dramatically increases ABT-737 lethality in human leukemia cells. ABT-737 induces Bax conf...

journal_title：Cancer research

authors： Chen S,Dai Y,Harada H,Dent P,Grant S

更新日期：2007-01-15 00:00:00

abstract：:In this study of the role of microfloral beta-glucuronidase in colonic carcinogenesis, the effect of beta-glucuronidase inhibitor was evaluated. Starting at 5 weeks of age, male Donryu rats were fed either a semisynthetic diet or the same diet containing 0.1% beta-glucuronidase inhibitor as N-cyclohexyl-5-O-acetyl-2,4...

journal_title：Cancer research

authors： Takada H,Hirooka T,Hiramatsu Y,Yamamoto M

更新日期：1982-01-01 00:00:00

abstract：:Our previous study showed that spleen cells from BALB/c mice bearing RL male 1 lymphoma inhibited the growth of RL male 1 lymphoma by the Winn-type adoptive transfer assay. Although this antitumor activity was mediated by the T-cell subset manifesting the surface phenotype of cytotoxic T-lymphocytes (CTLs), this antit...

journal_title：Cancer research

authors： Fuyama S,Yamamoto H,Fujii Y,Arai S

更新日期：1986-11-01 00:00:00

abstract：:Cytotoxic T lymphocytes can lyse Fc receptor-bearing target cells in vitro in the presence of anti-CD3 antibodies. This "redirected" lysis is not restricted by major histocompatibility antigens nor does it require nominal antigen recognition by the CTL. The efficacy of redirected lysis in vivo was assessed by comparin...

journal_title：Cancer research

authors： Usuba O,Ito M,Bona CA,Moran TM

更新日期：1990-09-15 00:00:00

abstract：:Osteosarcoma is the most common malignant bone tumor in children. Osteosarcoma patients who respond poorly to chemotherapy are at a higher risk of relapse and adverse outcome. Therefore, it was the aim of this study to identify prognostic factors at the time of diagnosis to characterize the genes predictive of poor su...

journal_title：Cancer research

authors： Mintz MB,Sowers R,Brown KM,Hilmer SC,Mazza B,Huvos AG,Meyers PA,Lafleur B,McDonough WS,Henry MM,Ramsey KE,Antonescu CR,Chen W,Healey JH,Daluski A,Berens ME,Macdonald TJ,Gorlick R,Stephan DA

更新日期：2005-03-01 00:00:00

abstract：:Gene transfer and expression of methotrexate (MTX)-resistant variants of dihydrofolate reductase (DHFR) in normal hematopoietic cells is a potential strategy to permit administration of larger doses of MTX by alleviating drug toxicity in normal cells and tissues that are drug sensitive. We have previously demonstrated...

journal_title：Cancer research

authors： Belur LR,Boelk-Galvan D,Diers MD,McIvor RS,Zimmerman CL

更新日期：2001-02-15 00:00:00

abstract：:Recently, loss or inactivation of genes at specific chromosomal loci has been considered to be one of the important mechanisms during the development of human tumors. In order to identify tumor suppressor genes for gastric carcinoma, we performed restriction fragment length polymorphism analysis on 48 human gastric ca...

journal_title：Cancer research

authors： Sano T,Tsujino T,Yoshida K,Nakayama H,Haruma K,Ito H,Nakamura Y,Kajiyama G,Tahara E

更新日期：1991-06-01 00:00:00

abstract：:This study describes a novel approach to the treatment of brain tumors with the combination of recombinant L-methionine-alpha-deamino-gamma-lyase and chemotherapeutic regimens that are currently used against such tumors. The growth of Daoy, SWB77, and D-54 xenografts in athymic mice was arrested after the depletion of...

journal_title：Cancer research

authors： Kokkinakis DM,Hoffman RM,Frenkel EP,Wick JB,Han Q,Xu M,Tan Y,Schold SC

更新日期：2001-05-15 00:00:00

abstract：:IgG monoclonal antibodies have made significant contributions to cancer therapy, but suffer from several limitations that restrict their effectiveness in unleashing host immune system components against tumors. The development of monoclonal antibodies of an alternative class, namely IgE, may offer enhanced immune surv...

journal_title：Cancer research

authors： Karagiannis SN,Josephs DH,Bax HJ,Spicer JF

更新日期：2017-06-01 00:00:00